Search Results

Filter
  • 1-10 of  75 results for ""Isocitrate Dehydrogenase""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

  • Authors : Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.

Subjects: Drug Resistance, Neoplasm* ; Mutation*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: The Lancet. Oncology [Lancet Oncol] 2020 Jun; Vol. 21 (6), pp. 796-807. Date of Electronic Publication: 2020 May 13.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.

  • Authors : Dai Y; Department of Oncology, First Affiliated Hospital of Jilin University, Changchun, 130021, China.; Ning X

Subjects: Mutation*; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*genetics ; Glioblastoma/Glioblastoma/Glioblastoma/*genetics

  • Source: Molecular neurobiology [Mol Neurobiol] 2016 Apr; Vol. 53 (3), pp. 1501-1508. Date of Electronic Publication: 2015 Feb 04.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.

Subjects: Glioma/Glioma/Glioma/*drug therapy ; Isocitrate Dehydrogenase/Isocitrate Dehydrogenase/Isocitrate Dehydrogenase/*genetics ; Temozolomide/Temozolomide/Temozolomide/*administration & dosage

  • Source: The Lancet. Oncology [Lancet Oncol] 2021 Jun; Vol. 22 (6), pp. 813-823. Date of Electronic Publication: 2021 May 14.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Novel SNP development and analysis at a NADP+ -specific IDH enzyme gene in a four species mixed oak forest.

  • Authors : Vidalis A; Department of Forest Genetics and Forest Tree Breeding, University of Göttingen, Büsgenweg 2, Göttingen, Germany. ; Curtu AL

Subjects: Linkage Disequilibrium* ; Polymorphism, Single Nucleotide*; Isocitrate Dehydrogenase/Isocitrate Dehydrogenase/Isocitrate Dehydrogenase/*genetics

  • Source: Plant biology (Stuttgart, Germany) [Plant Biol (Stuttg)] 2013 Jan; Vol. 15 Suppl 1, pp. 126-37. Date of Electronic Publication: 2012 May 22.Publisher: Wiley Country of Publication: England NLM ID: 101148926 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-8677

Record details

×
Academic Journal

TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.

Subjects: DNA Methylation* ; Mutation* ; Promoter Regions, Genetic*

  • Source: Journal of clinical pathology [J Clin Pathol] 2011 Oct; Vol. 64 (10), pp. 850-2. Date of Electronic Publication: 2011 Jun 20.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

ESNR 2023.

Subjects: AWARDS; CONFERENCES & conventions; NEURORADIOLOGYAUSTRIA; EUROPE

  • Source: Neuroradiology; 2023 Suppl 1, Vol. 65, p1-146, 146p

Record details

×
  • 1-10 of  75 results for ""Isocitrate Dehydrogenase""